Nicholas Hamm

After the failed merger, Walgreens gets go-ahead to purchase hundreds of Rite Aid stores.

A huge number of opioids go unused. So where do they go?

Rite Aid’s KidsCents will offer free flu shots to children.

The new machines will feature of variety of OTC meds and other products.

How one day could help your patients manage their meds.

Not all drugs are incredible-and sometimes even the incredible ones have weird origins.

The FIP awards honored two international pharmacy associations for their recent campaigns.

EpiPen manufacturer is accused of lax investigation into problems.

After trials halted, FDA issues warning on off-label use of the drug.

After Mylotarg was taken voluntarily taken off the market, the FDA is giving it a second chance.

A petition sent by multiple groups says yes.

In the midst of unprecedented disaster, pharmacists and pharmacies were prepared.

Why the agency says the approval of Novartis’ new therapy is historic.

The recall is just the latest in a bacterial contamination scare.

Robberies are never a good thing, but sometimes they make for the craziest stories.

Why the NABP says Canada isn't a safe alternative.

How pharmacists are helping to push vital health efforts.

The PBM giant is cutting down on the number of opioids new patients can buy.

The settlement is the end of a long legal battle.

When drug prices spike, health-care providers are forced to make tough choices.

FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.

New research suggests that the latest trend in opioids may not be so helpful.

The recall affects a variety of distributors.

Here's the technology your pharmacy might have in the next 10 years.

How the FDA is prioritizing drugs that offer the biggest health gains.

The agency says that the reduction lines up with current demand for opioids.

How one product is making it easier for your patients to safely dispose of their medications.

A new study shows that supplement exposure rates have been increasing-pharmacists have a responsibility to slow those rates.

Aspace Packaging recalls two drugs due to potential mislabeling.

The chain signs a deal with Fareva to take over its contract manufacturing business.